Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Femasys Inc
FEMY
Healthcare
Medical Devices
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes...
its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:FEMY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(279)
•••
whytestocks
X
Post by
whytestocks
on Oct 02, 2024 1:47pm
Femasys Receives Second Order from Spain Partners After
NEWS: $FEMY Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE
...more
(279)
•••
whytestocks
X
Post by
whytestocks
on Sep 18, 2024 1:15pm
Femasys Announces Infertility Clinic Customers from Coast to
JUST IN: $FEMY Femasys Announces Infertility Clinic Customers from Coast to CoastATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on
...more
(279)
•••
whytestocks
X
Post by
whytestocks
on Aug 08, 2024 9:32pm
Femasys Announces Financial Results for Quarter Ended June 3
Just In: $FEMY Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading
...more
(279)
•••
whytestocks
X
Post by
whytestocks
on Jun 17, 2024 3:45am
EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expe
BREAKING NEWS: $FEMY EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says | BenzingaFemasys Inc (NASDAQ:FEMY) is a biomedical
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 20, 2024 8:21am
FEMY....On watch at $2.12....NR
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 26, 2023 8:30am
New Press Release - Femasys Inc. EU MDR Final Audit Successfully Completed
– Completion of the European Union Medical Device Regulation (MDR) final audit is the last step in obtaining an MDR certificate and CE marking, confirming Femasys’ compliance with the highest required regulatory standards –– Femasys continues to fulfill its commitment to bring innovative...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 25, 2023 8:00am
New Press Release - Femasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women's Health at the American Association of Gynecologic Laparoscopic Surgeons
ATLANTA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 11, 2023 7:00am
New Press Release - Femasys Inc. Regains Compliance with Nasdaq Listing Requirements
ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 04, 2023 8:30am
New Press Release - Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine
ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2023 8:30am
New Press Release - Femasys Inc. MDSAP Surveillance Audit Successfully Completed
– Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA –– Femasys is committed to bringing innovative solutions to women around the world –ATLANTA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 29, 2023 10:47am
FEMY ..... What a shame
totally missed this one Surpassing my expectations for sure !!!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 28, 2023 12:09pm
FEMY..... movin
No position
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 27, 2023 12:11pm
FEMY.....yesterdays chasers have all been had....again
What a game !!!!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2023 12:11pm
FEMY.....LoL
Sold into that pop Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2023 11:51am
FEMY...running again
with volume spike
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments